Anthony Dobranowski
Director/Board Member at NUVO PHARMACEUTICALS INC.
Net worth: 31 500 $ as of 2024-04-29
Anthony Dobranowski active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUVO PHARMACEUTICALS INC. | Director/Board Member | 2004-09-20 | - |
| Independent Dir/Board Member | 2011-12-12 | - | |
| CRESCITA THERAPEUTICS INC. | Director/Board Member | 2016-02-29 | - |
| Independent Dir/Board Member | 2016-02-29 | - |
Career history of Anthony Dobranowski
Former positions of Anthony Dobranowski
| Companies | Position | Start | End |
|---|---|---|---|
| MAGNA INTERNATIONAL INC. | Corporate Officer/Principal | 2004-12-31 | 2007-08-31 |
Tesma International, Inc.
 Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Director/Board Member | 1994-12-31 | - |
| Director of Finance/CFO | 1994-12-31 | - | |
| President | 1994-12-31 | - | |
| Heating Oil Partners Income Fund | Director/Board Member | - | - |
Training of Anthony Dobranowski
| University of Toronto | Masters Business Admin |
Statistics
International
| Canada | 7 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Producer Manufacturing | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MAGNA INTERNATIONAL INC. | Producer Manufacturing |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
| Heating Oil Partners Income Fund | Miscellaneous |
Tesma International, Inc.
Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Producer Manufacturing |
- Stock Market
- Insiders
- Anthony Dobranowski
- Experience
